Sunday, February 6, 2011

Conflict of interest redux

City Pages digs deeper on the potential role of conflict of interest in UofM clinical trials in the death of Dan Markingson...Dr. Schulz does not come off well in this with drug company researchers, questionable presentation of data in this co-authored work, and accepting hundreds of thousands of dollars from drug companies for research, consulting fees, and other compensation . But perhaps most distressing:

In a separate deposition, Barden (note: a lawyer deposing Schulz) read an excerpt from a bioethics book arguing for the importance of informing patients about a doctor's financial ties to drug companies.

"Do you agree or disagree with that statement?" asked Barden

"I don't agree with that statement," replied Schulz, arguing that disclosing this information could "confuse" the situation.

No comments:

Post a Comment